Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N(2) non-small cell lung cancer

BACKGROUND: Pathological stage III/N(2) non-small cell lung cancer (NSCLC) is heterogeneous, and the optimal prognostic marker for survival remains unclear in Chinese patients. The aim of the present study was to assess the prognostic value of the clinicopathologic features and excision repair cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dong, Wei, Ping, An, Guangyu, Chen, Wenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681661/
https://www.ncbi.nlm.nih.gov/pubmed/23759026
http://dx.doi.org/10.1186/1749-8090-8-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681661/
https://www.ncbi.nlm.nih.gov/pubmed/23759026
http://dx.doi.org/10.1186/1749-8090-8-149

Ejemplares similares